Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Simon

Showing results (41-50 of 2,159) with videos related to

Pageof 216
Sort By:
Cancer Treatment Reports|October 1, 1985
Size of phase III cancer clinical trialsR Simon
Cancer|November 1, 1994
Randomized clinical trials in oncology. Principles and obstaclesR Simon
Molecular & General Genetics : MGG|January 1, 1984
High frequency mobilization of gram-negative bacterial replicons by the in vitro constructed Tn5-Mob transposonR Simon
Bulletin Du Cancer|January 1, 1991
The NCI program of therapeutic researchR Simon
American Journal of Epidemiology|April 1, 1980
Length biased sampling in etiologic studiesR Simon
Cancer Treatment Reports|January 1, 1984
Importance of prognostic factors in cancer clinical trialsR Simon
Journal of Biopharmaceutical Statistics|September 1, 1993
Why confidence intervals are useful tools in clinical therapeuticsR Simon
Biometrics|December 1, 1981
Composite randomization designs for clinical trialsR Simon
Cancer|June 1, 1980
Statistical methods for evaluating pregnancy outcomes in patients with Hodgkin's diseaseR Simon
American Journal of Epidemiology|January 1, 1980
Re: "Assessing effects of confounding variables"R Simon
Pageof 216

Showing results (41-50 of 2,159) with videos related to

Sort By:
Pageof 216
Cancer Treatment Reports|October 1, 1985
Size of phase III cancer clinical trialsR Simon
Cancer|November 1, 1994
Randomized clinical trials in oncology. Principles and obstaclesR Simon
Molecular & General Genetics : MGG|January 1, 1984
High frequency mobilization of gram-negative bacterial replicons by the in vitro constructed Tn5-Mob transposonR Simon
Bulletin Du Cancer|January 1, 1991
The NCI program of therapeutic researchR Simon
American Journal of Epidemiology|April 1, 1980
Length biased sampling in etiologic studiesR Simon
Cancer Treatment Reports|January 1, 1984
Importance of prognostic factors in cancer clinical trialsR Simon
Journal of Biopharmaceutical Statistics|September 1, 1993
Why confidence intervals are useful tools in clinical therapeuticsR Simon
Biometrics|December 1, 1981
Composite randomization designs for clinical trialsR Simon
Cancer|June 1, 1980
Statistical methods for evaluating pregnancy outcomes in patients with Hodgkin's diseaseR Simon
American Journal of Epidemiology|January 1, 1980
Re: "Assessing effects of confounding variables"R Simon
Pageof 216